Pathogenesis and treatment of autoimmunity
Featured projects
-
Decision on optimal combinatorial therapies in IMIDS using systems approaches
Principal investigator: Pere Santamaria Vilanova.Funder: European Commission .Code: CE -H2020-SC1_2019_2s.Duration: 01/01/2020 - 31/12/2025The role of autophagy in central tolerance and peripheral activation of diabetogenic T-cells
Principal investigator: Pere Santamaria Vilanova.Funder: Ministerio de Economia y Competitividad (MINECO .Code: RTI2018-093964-B-I00.Duration: 01/01/2019 - 30/09/2022Autoimmunity Research Group funding
Principal investigator: Pere Santamaria Vilanova.Funder: Generalitat de Catalunya .Code: AGAUR–SGR17–00338.Duration: 01/01/2018 - 31/12/2019Nanomedicines for autoimmune diseases
Principal investigator: Pere Santamaria Vilanova.Funder: Industry Sponsored Research .Duration: 01/04/2017REEM (RETICS), Spanish network for Multiple Sclerosis
Principal investigator: Pere Santamaria Vilanova.Funder: Instituto de Salud Carlos III .Code: RD16/0015/0020.Duration: 01/01/2017 - 31/12/2022El papel de la autofagia celular en la tolerancia central y activación periférica de células TCD4+ diabetogénicas.
Principal investigator: Pere Santamaria Vilanova.Funder: Ministerio de Economia y Competitividad (MINECO) .Code: SAF2015-68187-R.Duration: 01/01/2016 - 31/12/2019Advancing human antigen-specific T-regulatory cell expanding nanomedicines for autoimmune disease: Translational studies in humanized mice.
Principal investigator: Pau Serra Devecchi, Pere Santamaria Vilanova, Pablo Villoslada Diaz, Albert Pares Darnaculleta, Ignacio Conget Donlo.Funder: Instituto de Salud Carlos III .Code: PIE14/00027.Duration: 01/01/2015 - 30/06/2019Autoimmunity Research Group funding
Principal investigator: Pere Santamaria Vilanova.Funder: Generalitat de Catalunya .Duration: 01/01/2014 - 31/12/2017More about researchCheck job offersIDIBAPS looks for talented professionals to meet the needs that appear periodically.
Enter